Nnenaya Agochukwu-Mmonu1,2,3, Jonathan B Wiseman4, Abigail R Smith4, Margaret E Helmuth4, Aruna V Sarma1,2, Anne P Cameron1, Cindy L Amundsen5, Kathryn E Flynn6, David Cella7, Kevin P Weinfurt5, Ziya Kirkali8, J Quentin Clemens1,2. 1. Department of Urology, University of Michigan Health System, Ann Arbor, Michigan. 2. Michigan Medicine Department of Urology, Dow Division of Health Services Research, Ann Arbor, Michigan. 3. Department of Urology, New York University Langone Medical Center, New York, New York. 4. Arbor Research Collaborative for Health, Ann Arbor, Michigan. 5. Department of Obstetrics and Gynecology, Duke University, Durham, North Carolina. 6. Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin. 7. Department of Medical Social Sciences, Northwestern University, Chicago, Illinois. 8. National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland.
Abstract
AIMS: Bother attributed to lower urinary tract symptoms (LUTS) drives care-seeking and treatment aggressiveness. The longitudinal relationship of LUTS severity and bother in a care-seeking cohort, however, is not well understood. We aim to conduct a longitudinal evaluation of LUTS severity and bother and identify characteristics of patients with discordant LUTS bother relative to severity. METHODS: Men and women with LUTS seeking care at six US tertiary care centers enrolled in the symptoms of lower urinary tract dysfunction research network study. Patients reporting at least one urinary symptom based on the LUTS Tool were prospectively enrolled from June 2015 to January 2017. Correlations were used to assess the relationship between LUTS severity and bother. Discordance scores (ie, the difference between bother and severity) were used to classify patients with high and low bother. Patients were classified as having high or low bother phenotypes if scores were one standard deviation above or below zero, respectively. Repeated measures multinomial logistic regression evaluated characteristics associated with high and low bother phenotypes. RESULTS: LUTS severity and bother were at least moderately correlated for all symptom items and highly correlated for 13 out of 21 items. Correlations were highest for urgency, and lowest for daytime frequency and urinary incontinence. Odds of being in high bother phenotype were lowest at 3 and 12 months (3 months vs baseline odds ratio [OR] = 0.71, 95% confidence ninterval [CI] = 0.54-0.94; 12 months vs baseline OR = 0.66, 95% CI = 0.48-0.91), and highest for those who endorsed all urgency questions (OR = 3.65, 95% CI = 2.17-6.13). Odds of being in the low bother phenotype were lowest for patients who endorsed all urgency items (OR = 0.33, 95% CI = 0.26-0.42), and all frequency items (OR = 0.68, 95% CI = 0.53-0.88). CONCLUSIONS: LUTS severity and bother correlate highly and measurement of both in clinical practice is likely redundant. There are patient factors associated with discordance which may justify additional evaluation.
AIMS: Bother attributed to lower urinary tract symptoms (LUTS) drives care-seeking and treatment aggressiveness. The longitudinal relationship of LUTS severity and bother in a care-seeking cohort, however, is not well understood. We aim to conduct a longitudinal evaluation of LUTS severity and bother and identify characteristics of patients with discordant LUTS bother relative to severity. METHODS: Men and women with LUTS seeking care at six US tertiary care centers enrolled in the symptoms of lower urinary tract dysfunction research network study. Patients reporting at least one urinary symptom based on the LUTS Tool were prospectively enrolled from June 2015 to January 2017. Correlations were used to assess the relationship between LUTS severity and bother. Discordance scores (ie, the difference between bother and severity) were used to classify patients with high and low bother. Patients were classified as having high or low bother phenotypes if scores were one standard deviation above or below zero, respectively. Repeated measures multinomial logistic regression evaluated characteristics associated with high and low bother phenotypes. RESULTS: LUTS severity and bother were at least moderately correlated for all symptom items and highly correlated for 13 out of 21 items. Correlations were highest for urgency, and lowest for daytime frequency and urinary incontinence. Odds of being in high bother phenotype were lowest at 3 and 12 months (3 months vs baseline odds ratio [OR] = 0.71, 95% confidence ninterval [CI] = 0.54-0.94; 12 months vs baseline OR = 0.66, 95% CI = 0.48-0.91), and highest for those who endorsed all urgency questions (OR = 3.65, 95% CI = 2.17-6.13). Odds of being in the low bother phenotype were lowest for patients who endorsed all urgency items (OR = 0.33, 95% CI = 0.26-0.42), and all frequency items (OR = 0.68, 95% CI = 0.53-0.88). CONCLUSIONS: LUTS severity and bother correlate highly and measurement of both in clinical practice is likely redundant. There are patient factors associated with discordance which may justify additional evaluation.
Authors: Debra E Irwin; Ian Milsom; Steinar Hunskaar; Kate Reilly; Zoe Kopp; Sender Herschorn; Karin Coyne; Con Kelleher; Christian Hampel; Walter Artibani; Paul Abrams Journal: Eur Urol Date: 2006-10-02 Impact factor: 20.096
Authors: Brennan M R Spiegel; Ron D Hays; Roger Bolus; Gil Y Melmed; Lin Chang; Cynthia Whitman; Puja P Khanna; Sylvia H Paz; Tonya Hays; Steve Reise; Dinesh Khanna Journal: Am J Gastroenterol Date: 2014-09-09 Impact factor: 10.864
Authors: Karin S Coyne; Alan J Wein; Andrea Tubaro; Chris C Sexton; Christine L Thompson; Zoe S Kopp; Lalitha P Aiyer Journal: BJU Int Date: 2009-04 Impact factor: 5.588
Authors: Arnav Agarwal; Leyla N Eryuzlu; Rufus Cartwright; Kristian Thorlund; Teuvo L J Tammela; Gordon H Guyatt; Anssi Auvinen; Kari A O Tikkinen Journal: Eur Urol Date: 2014-01-24 Impact factor: 20.096
Authors: Giulia I Lane; Ji Qi; Ajith Dupati; Stephanie Ferrante; Rodney L Dunn; Roshan Paudel; Daniela Wittmann; Lauren P Wallner; Donna L Berry; Chad Ellimoottil; James E Montie; J Quentin Clemens Journal: Urology Date: 2022-02-24 Impact factor: 2.633